ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2015

Combined therapy with thrombospondin-1 type I repeats (3TSR) and chemotherapy induces regression and significantly improves survival in a preclinical model of advanced stage epithelial ovarian cancer.

Samantha Russell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.